Jennison Associates’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-252,708
| Closed | -$1M | – | 665 |
|
|
2019
Q1 | $1M | Sell |
252,708
-1,379,938
| -85% | -$5.48M | ﹤0.01% | 540 |
|
|
2018
Q4 | $6.5M | Sell |
1,632,646
-703,343
| -30% | -$2.8M | 0.01% | 466 |
|
|
2018
Q3 | $16.1M | Buy |
2,335,989
+16,734
| +0.7% | +$115K | 0.01% | 423 |
|
|
2018
Q2 | $15.7M | Buy |
2,319,255
+26,503
| +1% | +$179K | 0.02% | 429 |
|
|
2018
Q1 | $14.9M | Buy |
2,292,752
+297,984
| +15% | +$1.94M | 0.01% | 427 |
|
|
2017
Q4 | $8.88M | Buy |
1,994,768
+20,132
| +1% | +$89.6K | 0.01% | 470 |
|
|
2017
Q3 | $12.2M | Sell |
1,974,636
-10,860
| -0.5% | -$67.1K | 0.01% | 460 |
|
|
2017
Q2 | $18.4M | Sell |
1,985,496
-1,231,385
| -38% | -$11.4M | 0.02% | 417 |
|
|
2017
Q1 | $29.9M | Hold |
3,216,881
| – | – | 0.03% | 362 |
|
|
2016
Q4 | $26.9M | Buy |
3,216,881
+212,360
| +7% | +$1.78M | 0.03% | 371 |
|
|
2016
Q3 | $20.6M | Buy |
3,004,521
+31,915
| +1% | +$219K | 0.02% | 404 |
|
|
2016
Q2 | $14.7M | Buy |
2,972,606
+1,643,261
| +124% | +$8.13M | 0.02% | 430 |
|
|
2016
Q1 | $12.8M | Buy |
1,329,345
+648,468
| +95% | +$6.26M | 0.01% | 439 |
|
|
2015
Q4 | $6.38M | Sell |
680,877
-89,355
| -12% | -$837K | 0.01% | 499 |
|
|
2015
Q3 | $10.8M | Buy |
770,232
+3,953
| +0.5% | +$55.6K | 0.01% | 497 |
|
|
2015
Q2 | $16.1M | Buy |
766,279
+627,861
| +454% | +$13.2M | 0.01% | 472 |
|
|
2015
Q1 | $5.81M | Buy |
+138,418
| New | +$5.81M | 0.01% | 506 |
|